![Andrew LaFrence](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew LaFrence
Finanzdirektor/CFO bei
NORTECH SYSTEMS INCORPORATED
Vermögen: 445 463 $ am 31.05.2026
Profil
Andrew D.
C.
LaFrence is Chairman at University Enterprise Labs, Director at EarthClean Corp., Director at American National Bank (Omaha, Nebraska) since 2015, Director at InSitu Biologics, Inc., Independent Director at Skywater Technology, Inc. starting 2025, and Chief Financial Officer & Senior VP-Finance at Nortech Systems, Inc. since 2023.
Former roles include Director at Biothera, Inc., Director at Biothera Holding Corp., Director at NuAx, Inc., Chief Financial Officer at KORU Medical Systems, Inc. in 2023, Chief Financial Officer & Vice President at Surmodics, Inc. from 2013 to 2018, Chief Financial Officer at CNS Therapeutics, Inc., Audit Partner at KPMG LLP, President, Chief Executive & Financial Officer at Vyant Bio, Inc. from 2019 to 2023, Chief Financial Officer & Senior Vice President at Biothera Pharmaceuticals, Inc. (Delaware) from 2018 to 2019, and Chief Operating & Financial Officer at StemoniX, Inc. from 2019 to 2021.
Education includes an undergraduate degree from Illinois State University, conferred in 1984.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SKYWATER TECHNOLOGY INC 0,02 % | 13.04.2026 | 11 428 ( 0,02 % ) | 445 463 $ | 31.05.2026 |
| 20.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Andrew LaFrence
| Unternehmen | Position | Beginn |
|---|---|---|
| NORTECH SYSTEMS INCORPORATED | Finanzdirektor/CFO | 01.12.2023 |
| SKYWATER TECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 31.03.2025 |
University Enterprise Labs | Vorsitzender | - |
American National Bank (Omaha, Nebraska)
 American National Bank (Omaha, Nebraska) Major BanksFinance Operates as a national chartered commercial bank | Direktor/Vorstandsmitglied | 01.06.2015 |
InSitu Biologics, Inc.
 InSitu Biologics, Inc. BiotechnologyHealth Technology Provides drug delivery services | Direktor/Vorstandsmitglied | - |
EarthClean Corp.
 EarthClean Corp. Industrial ConglomeratesProducer Manufacturing Provides manufacturing services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andrew LaFrence
| Unternehmen | Position | Ende |
|---|---|---|
| VYANT BIO, INC. | Vorstandsvorsitzender | 01.11.2023 |
| KORU MEDICAL SYSTEMS, INC. | Finanzdirektor/CFO | 01.08.2023 |
StemoniX, Inc.
 StemoniX, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in toxicology and drug discovery research | Finanzdirektor/CFO | 01.01.2021 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Andrew LaFrence
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Nortech Systems, Inc.
 Nortech Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
KORU Medical Systems, Inc.
 KORU Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes portable medical devices | Health Technology |
Surmodics, Inc.
 Surmodics, Inc. Medical SpecialtiesHealth Technology Provides surface modification and in vitro diagnostic technology services to the healthcare industry | Health Technology |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug delivery products | Health Technology |
EarthClean Corp.
EarthClean Corp. Industrial ConglomeratesProducer Manufacturing Provides manufacturing services | Producer Manufacturing |
Biothera Holding Corp.
 Biothera Holding Corp. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Illinois State University
 Illinois State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuAx, Inc.
 NuAx, Inc. Medical SpecialtiesHealth Technology Develops medical device for the treatment of heart disease | Health Technology |
American National Bank (Omaha, Nebraska)
American National Bank (Omaha, Nebraska) Major BanksFinance Operates as a national chartered commercial bank | Finance |
Biothera Pharmaceuticals, Inc. (Delaware)
 Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
StemoniX, Inc.
StemoniX, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in toxicology and drug discovery research | Commercial Services |
InSitu Biologics, Inc.
InSitu Biologics, Inc. BiotechnologyHealth Technology Provides drug delivery services | Health Technology |
Skywater Technology, Inc.
 Skywater Technology, Inc. Industrial MachineryProducer Manufacturing Provides wafer services | Producer Manufacturing |
Vyant Bio, Inc.
 Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University Enterprise Labs |
